Improving heart and kidney care through smart prescribing in diabetes
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether using electronic health records can help doctors prescribe better medications for people with type 2 diabetes who have protein in their urine. These medications are designed to protect your heart and kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with type 2 diabetes
- You receive care at Baylor Scott & White Health clinics
- You have had at least one clinic visit in the past 12 months
- Your urine test shows protein (albuminuria), which may signal kidney stress
- Your kidney function and blood potassium levels are stable enough for safe treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether starting four blood-pressure and kidney-protective medications at the same time is safe and effective for people with type 2 diabetes and early kidney disease. The goal is to slow kidney damage and reduce heart and kidney problems.
This study tests whether having a pharmacist prescribe kidney-protective medications works better than usual care for people with type 2 diabetes and early kidney disease. If you don't have a family doctor, you may be able to get these medications more easily through a pharmacist.
This study looks at how well a simple urine test can track chronic kidney disease (CKD) and whether SGLT2 inhibitors (a type of diabetes medicine also used for kidney protection) work in real life. It might help find better ways to manage your condition.
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
This study tests a personalized medication approach to lower kidney and heart risks in people with type 2 diabetes and early-to-moderate kidney disease. It may help you if you have a high chance of heart problems and can start new medications.
This study tests a program to help primary care doctors better screen and manage kidney problems in people with type 2 diabetes. It aims to see if using recommended medicines can slow kidney disease and improve health.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.